文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

帕金森病预后模型的系统评价

Systematic review of prognostic models in Parkinson's disease.

作者信息

Li Yan, McDonald-Webb Millie, McLernon David J, Counsell Carl E, Macleod Angus D

机构信息

Institute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, UK.

School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, UK.

出版信息

NPJ Parkinsons Dis. 2025 Aug 29;11(1):266. doi: 10.1038/s41531-025-01112-x.


DOI:10.1038/s41531-025-01112-x
PMID:40883335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12397436/
Abstract

Predicting outcomes for people with Parkinson's (PwP) can enable better information provision, personalised treatments, and enhanced trial design. It is unclear what prognostic models are optimal for use. We systematically reviewed previously published prognostic models for PwP, assessed quality, and made recommendations. We searched MEDLINE and EMBASE for studies developing/validating models predicting clinical outcomes in PwP. We assessed risk of bias and applicability using the PROBAST tool. We screened 1024 references and identified 25 studies (41 prognostic models). The most common outcomes were falls (11 studies), dementia (7) and motor complications (4). Most models made short-term predictions (60% ≤2 years). All studies had concerns about bias, e.g., inadequate population details (n = 16), suboptimal methods for missing data (n = 21), and no external validation (n = 22). 13 models had sufficient information to be used in practice. Further development and validation of prognostic models is needed which follows existing guidelines to reduce risk of bias.

摘要

预测帕金森病患者(PwP)的预后可以提供更好的信息、个性化治疗并优化试验设计。目前尚不清楚哪种预后模型是最适合使用的。我们系统回顾了先前发表的针对PwP的预后模型,评估了其质量并给出了建议。我们在MEDLINE和EMBASE中检索了开发/验证预测PwP临床结局模型的研究。我们使用PROBAST工具评估偏倚风险和适用性。我们筛选了1024篇参考文献,确定了25项研究(41种预后模型)。最常见的结局是跌倒(11项研究)、痴呆(7项)和运动并发症(4项)。大多数模型进行短期预测(60%≤2年)。所有研究都存在偏倚问题,例如,人群细节不足(n = 16)、处理缺失数据的方法欠佳(n = 21)以及缺乏外部验证(n = 22)。13种模型有足够的信息可用于实际应用。需要按照现有指南进一步开发和验证预后模型,以降低偏倚风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6813/12397436/31aa18f17d60/41531_2025_1112_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6813/12397436/31aa18f17d60/41531_2025_1112_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6813/12397436/31aa18f17d60/41531_2025_1112_Fig2_HTML.jpg

相似文献

[1]
Systematic review of prognostic models in Parkinson's disease.

NPJ Parkinsons Dis. 2025-8-29

[2]
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Cochrane Database Syst Rev. 2021-12-21

[3]
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.

Syst Rev. 2024-11-26

[4]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[5]
Interventions for preventing falls in older people in care facilities.

Cochrane Database Syst Rev. 2025-8-20

[6]
Interventions for preventing and reducing the use of physical restraints for older people in all long-term care settings.

Cochrane Database Syst Rev. 2023-7-28

[7]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

[8]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2025-8-6

[9]
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.

Cochrane Database Syst Rev. 2022-6-16

[10]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

本文引用的文献

[1]
Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models.

Ann Intern Med. 2023-1

[2]
Validation of prediction models in the presence of competing risks: a guide through modern methods.

BMJ. 2022-5-24

[3]
External validation of prognostic models: what, why, how, when and where?

Clin Kidney J. 2020-11-24

[4]
Multivariate prediction of dementia in Parkinson's disease.

NPJ Parkinsons Dis. 2020-8-25

[5]
Regression with a right-censored predictor using inverse probability weighting methods.

Stat Med. 2020-11-30

[6]
Calculating the sample size required for developing a clinical prediction model.

BMJ. 2020-3-18

[7]
Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort study.

J Affect Disord. 2020-5-1

[8]
Calibration: the Achilles heel of predictive analytics.

BMC Med. 2019-12-16

[9]
Predicting motor, cognitive & functional impairment in Parkinson's.

Ann Clin Transl Neurol. 2019-7-26

[10]
Predictors of motor complications in early Parkinson's disease: A prospective cohort study.

Mov Disord. 2019-7-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索